Mutational Analysis of AKT1 and PIK3CA in Intraductal Papillomas of the Breast with Special Reference to Cellular Components

被引:15
|
作者
Mishima, Chieko [1 ]
Kagara, Naofumi [1 ]
Ikeda, Jun-ichiro [2 ]
Morii, Eiichi [2 ]
Miyake, Tomohiro [1 ]
Tanei, Tomonori [1 ]
Naoi, Yasuto [1 ]
Shimoda, Masafumi [1 ]
Shimazu, Kenzo [1 ]
Kim, Seung Jin [1 ]
Noguchi, Shinzaburo [1 ]
机构
[1] Osaka Univ, Grad Sch Med, Dept Breast & Endocrine Surg, 2-2-E10 Yamadaoka, Suita, Osaka, Japan
[2] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka, Japan
来源
AMERICAN JOURNAL OF PATHOLOGY | 2018年 / 188卷 / 05期
关键词
POLYMERASE-CHAIN-REACTION; DUCTAL HYPERPLASIA; CLONAL ANALYSIS; MAMMARY-GLAND; CANCER; SUBSEQUENT; PATHWAY; BENIGN; RISK;
D O I
10.1016/j.ajpath.2018.01.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The pathologic feature of intraductal papillomas is defined as a papillary structure composed of a fibrovascular stromal core lined by luminal epithelial cells and myoepithelial cells. We used droplet digital PCR for the mutational analysis of AKT1 (E17K) and PIK3CA (H1047R, E542K, and E545K) in 60 papillomas. AKT1 and PIK3CA mutations were detected in 12 (20%) and 17 (28%) of the papillomas, respectively. In five tumors harboring mutations, mutational analysis of AKT1 or PIK3CA was performed separately using luminal epithelial cells and myoepithelial cells sorted using anti cytokeratin 19 antibody and anti a smooth muscle actin antibody. The two types of cells from a given papilloma had the identical mutation. Three patients with the PIK3CA mutation positive papilloma developed breast cancers at the resection site of the papilloma, but none of these subsequent breast cancers had the PIK3CA mutation. These results indicate that a papilloma stems from a bipotent progenitor cell that contains the AKT1 or PIK3CA mutation and proliferates and differentiates to form the papilloma. Papilloma can be a risk factor for developing breast cancer but is unlikely to be its obligate precursor.
引用
收藏
页码:1106 / 1112
页数:7
相关论文
共 50 条
  • [21] Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer
    Herberts, Cameron
    Murtha, Andrew J.
    Fu, Simon
    Wang, Gang
    Schonlau, Elena
    Xue, Hui
    Lin, Dong
    Gleave, Anna
    Yip, Steven
    Angeles, Arkhjamil
    Hotte, Sebastien
    Tran, Ben
    North, Scott
    Taavitsainen, Sinja
    Beja, Kevin
    Vandekerkhove, Gillian
    Ritch, Elie
    Warner, Evan
    Saad, Fred
    Iqbal, Nayyer
    Nykter, Matti
    Gleave, Martin E.
    Wang, Yuzhuo
    Annala, Matti
    Chi, Kim N.
    Wyatt, Alexander W.
    EUROPEAN UROLOGY, 2020, 78 (06) : 834 - 844
  • [22] Mutational analysis of PIK3CA, JAK2, BRAF, FOXL2, IDH1, AKT1 and EZH2 oncogenes in sarcomas
    Je, Eun M.
    An, Chang H.
    Yoo, Nam J.
    Lee, Sug H.
    APMIS, 2012, 120 (08) : 635 - 639
  • [23] Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
    Miguel Cejalvo, Juan
    Alejandro Perez-Fidalgo, J.
    Ribas, Gloria
    Burgues, Octavio
    Mongort, Cristina
    Alonso, Elisa
    Ibarrola-Villava, Maider
    Bermejo, Begona
    Teresa Martinez, Maria
    Cervantes, Andres
    Lluch, Ana
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 160 (01) : 69 - 77
  • [24] Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 and KRAS/NRAS/BRAF in metastatic breast cancer
    Juan Miguel Cejalvo
    J. Alejandro Pérez-Fidalgo
    Gloria Ribas
    Octavio Burgués
    Cristina Mongort
    Elisa Alonso
    Maider Ibarrola-Villava
    Begoña Bermejo
    María Teresa Martínez
    Andrés Cervantes
    Ana Lluch
    Breast Cancer Research and Treatment, 2016, 160 : 69 - 77
  • [25] Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients
    Li, Guoli
    Guo, Xinwu
    Chen, Ming
    Tang, Lili
    Jiang, Hui
    Day, Julia X.
    Xie, Yueliang
    Peng, Limin
    Xu, Xunxun
    Li, Jinliang
    Wang, Shouman
    Xiao, Zhi
    Dai, Lizhong
    Wang, Jun
    PLOS ONE, 2018, 13 (09):
  • [26] Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants
    Tian, Wen
    Huang, Yingzhao
    Sun, Liying
    Guo, Yang
    Zhao, Sen
    Lin, Mao
    Dong, Xiying
    Zhong, Wenyao
    Yin, Yuehan
    Chen, Zefu
    Zhang, Nan
    Zhang, Yuanqiang
    Wang, Lianlei
    Lin, Jiachen
    Yan, Zihui
    Yang, Xinzhuang
    Zhao, Junhui
    Qiu, Guixing
    Zhang, Jianguo
    Wu, Zhihong
    Wu, Nan
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [27] AKT1 and PIK3CA activating mutations in Moroccan bladder cancer patients' biopsies and matched urine
    El Ahanidi, Hajar
    El Azzouzi, Meryem
    Arrouchi, Housna
    Alaoui, Chaimae Hafidi
    Tetou, Mohammed
    Bensaid, Mounia
    Oukabli, Mohamed
    Ameur, Ahmed
    Al Bouzidi, Abderrahmane
    El Mzibri, Mohammed
    Attaleb, Mohammed
    PAN AFRICAN MEDICAL JOURNAL, 2022, 41
  • [28] Phenotypic and genetic spectrum of isolated macrodactyly: somatic mosaicism of PIK3CA and AKT1 oncogenic variants
    Wen Tian
    Yingzhao Huang
    Liying Sun
    Yang Guo
    Sen Zhao
    Mao Lin
    Xiying Dong
    Wenyao Zhong
    Yuehan Yin
    Zefu Chen
    Nan Zhang
    Yuanqiang Zhang
    Lianlei Wang
    Jiachen Lin
    Zihui Yan
    Xinzhuang Yang
    Junhui Zhao
    Guixing Qiu
    Jianguo Zhang
    Zhihong Wu
    Nan Wu
    Orphanet Journal of Rare Diseases, 15
  • [29] Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients -: The effect of pik3ca pseudogene on mutational analysis
    Tanaka, Yasuo
    Kanai, Fumihiko
    Tada, Motohisa
    Asaoka, Yoshinan
    Guleng, Bayasi
    Jazag, Amarsanaa
    Ohta, Miki
    Ikenoue, Tsuneo
    Tateishi, Keisuke
    Obi, Shuntaro
    Kawabe, Takao
    Yokosuka, Osamu
    Omata, Masao
    GASTROENTEROLOGY, 2006, 130 (04) : A832 - A832
  • [30] PIK3CA mutations are rare in neuroblastoma: development and use of a highly sensitive dHPLC assay for the mutational analysis of PIK3CA
    Kim, Youngjin
    Yu, Alice L.
    Diccianni, Mitchell B.
    CANCER RESEARCH, 2006, 66 (08)